Back to Journals » Drug Design, Development and Therapy » Volume 9

Brentuximab vedotin for relapsed or refractory Hodgkin’s lymphoma

Total article views   HTML views PDF downloads Totals
11,572 Dovepress* 9,041+ 1,834 10,875
PubMed Central* 2,531 685 3,216
Totals 11,572 2,519 14,091
*Since 23 March 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar